Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natasha Ludmila Bosch"'
Autor:
Viviane Bernardes de Oliveira Chaiben, Thabata Baechtold da Silveira, Murilo Henrique Guedes, João Pedro de Almeida Fernandes, João Henrique Fregadolli Ferreira, Julianna Beltrão, Giovanna Foltran Leal, Lucas Henrique Olandoski Erbano, Natasha Ludmila Bosch, Roberto Pecoits Filho, Thyago Proença de Moraes, Cristina Pellegrino Baena
Publikováno v:
Brazilian Journal of Nephrology, Iss 0 (2018)
ABSTRACT Introduction: The prevalence of chronic kidney disease (CKD) is increasing, with a potential impact in the risk of acceleration of dementia. The potential association between glomerular filtration rate (eGFR) and cognitive performance was sc
Externí odkaz:
https://doaj.org/article/ca8cafa3005b44ebb7b35613221c172a
Autor:
Viviane B. de Oliveira Chaiben, Natasha Ludmila Bosch, João Henrique Fregadolli Ferreira, João Pedro de Almeida Fernandes, Julianna Rodrigues Beltrão, Cristina Pellegrino Baena, Thyago Proença de Moraes, Giovanna Foltran Leal, Thabata Baechtold da Silveira, Roberto Pecoits Filho, Murilo Guedes, Lucas Henrique Olandoski Erbano
Publikováno v:
Brazilian Journal of Nephrology, Iss 0 (2018)
Brazilian Journal of Nephrology, Issue: ahead, Published: 13 SEP 2018
Brazilian Journal of Nephrology, Volume: 41, Issue: 2, Pages: 200-207, Published: 13 SEP 2018
Brazilian Journal of Nephrology v.41 n.2 2019
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Brazilian Journal of Nephrology, Issue: ahead, Published: 13 SEP 2018
Brazilian Journal of Nephrology, Volume: 41, Issue: 2, Pages: 200-207, Published: 13 SEP 2018
Brazilian Journal of Nephrology v.41 n.2 2019
Jornal Brasileiro de Nefrologia
Sociedade Brasileira de Nefrologia (SBN)
instacron:SBN
Introduction: The prevalence of chronic kidney disease (CKD) is increasing, with a potential impact in the risk of acceleration of dementia. The potential association between glomerular filtration rate (eGFR) and cognitive performance was scarcely st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b369f2b97398da2f25c798806253be
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018005032102&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018005032102&lng=en&tlng=en
Autor:
Cristina Pellegrino Baena, Elise L. Tierie, Luara de Aragão Miguita, Natasha Ludmila Bosch, Lidia Zytinski, Camila Hartmann
Publikováno v:
International Journal of Clinical Pharmacy, 40(6), 1443-1453. Springer Netherlands
Background Ivabradine is currently indicated to lower heart rate in Heart Failure with Reduced Ejection Fraction (HFrEF) patients. However its effect apart from beta-blockers is not clear. Aim of the review To study the additional effect of ivabradin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f31cb3ae224f58ae7db9445944183b51
https://pubmed.ncbi.nlm.nih.gov/30173307
https://pubmed.ncbi.nlm.nih.gov/30173307